Community health workers can help protect pregnantwomen and their babies from malaria ISGLOBALorg
Malaria during pregnancy puts the health of both mother and child at risk. In 2020, an estimated 11.6 million pregnancies in Africa were exposed to malaria infection, resulting in 11% of neonatal deaths and 20% stillbirths. For this reason, the WHO recommends that pregnantreceive three doses of the antimalarial drug sulfadoxine-pyrimethamine during their antenatal visits if they live in areas with high to moderate malaria transmission.
"This study is the largest implementation project carried out in collaboration with the countries' ministries of health, in which we simultaneously evaluated the impact of community health workers on IPTp coverage and antenatal care attendance," explains Raquel González, TIPTOP senior epidemiologist and lead author of the study.
The results show that IPTp coverage increased significantly after the community-based implementation in all study countries, ranging from 133.6% in Madagascar to 473% in Nigeria, where coverage increased from 12.7% to 31.8%. Importantly, the approach did not reduce antenatal care attendance. On the contrary, it increased slightly in most study areas.
"These results are robust and will help to inform malaria control strategies," says Clara Menéndez. Approximately 10,000 pregnant women and 200,000 of their newborns die each year from malaria, which means that increasing IPTp uptake through community health workers can save thousands of maternal and infant lives in African countries.
"We're delighted to see these community-led approaches making a difference in the lives of thousands of pregnant women. Beyond achieving targets, TIPTOP has underscored the critical role community health workers play in supporting the health of women, where they live," said Elaine Roman, TIPTOP Project Director.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Recent Biden Decision Gives LGBTQ Community Reason to WorryBiden has been the most consistently supportive President for LGBTQ rights ever. But a recent move could give the community a reason to worry
Read more »
A community torn apart by the lies of Ellie Williams, told in their own wordsThroughout today’s court proceedings, petite Williams sat emotionless as statements from her victims and community leaders set out the harm caused by Williams’ web of lies
Read more »
The 50-year-old Stockport community centre that's been served an eviction notice'It keeps our girls out of trouble, it develops their life skills, social skills and brings the community together.'
Read more »
Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate CancerBackground: Germline testing for prostate cancer is on the increase, with clinical implications for risk assessment, treatment, and management. Regardless of family history, NCCN recommends germline testing for patients with metastatic, regional, very-high-risk localized, and high-risk localized prostate cancer. Although African ancestry is a significant risk factor for aggressive prostate cancer, due to a lack of available data no testing criteria have been established for ethnic minorities. Patients and Methods: Through deep sequencing, we interrogated the 20 most common germline testing panel genes in 113 Black South African males presenting with largely advanced prostate cancer. Bioinformatic tools were then used to identify the pathogenicity of the variants. Results: After we identified 39 predicted deleterious variants (16 genes), further computational annotation classified 17 variants as potentially oncogenic (12 genes; 17.7% of patients). Rare pathogenic variants included CHEK2 Arg95Ter, BRCA2 Trp31Arg, ATM Arg3047Ter (2 patients), and TP53 Arg282Trp. Notable oncogenic variants of unknown pathogenicity included novel BRCA2 Leu3038Ile in a patient with early-onset disease, whereas patients with FANCA Arg504Cys and RAD51C Arg260Gln reported a family history of prostate cancer. Overall, rare pathogenic and early-onset or familial-associated oncogenic variants were identified in 6.9% (5/72) and 9.2% (8/87) of patients presenting with a Gleason score ≥8 or ≥4 + 3 prostate cancer, respectively. Conclusions: In this first-of-its-kind study of southern African males, we provide support of African inclusion for advanced, early-onset, and familial prostate cancer genetic testing, indicating clinical value for 30% of current gene panels. Recognizing current panel limitations highlights an urgent need to establish testing guidelines for men of African ancestry. We provide a rationale for considering lowering the pathologic diagnostic inclusion criteria and call for furt
Read more »
Danai Gurira’s Towering Oscars Updo Is A Stunning Ode To African WomenDanai Gurira stepped out on the red carpet wearing a towering updo that doubled as an homage.
Read more »